HPV vaccine study for Chinese women who had or never had HPV vaccine
Part of Infections clinical trials.
This study tests a new HPV vaccine in Chinese women. It looks at whether the vaccine is safe and effective for women who have already had a different HPV vaccine (the bivalent one) and for women who have never had any HPV vaccine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman living in China.
- You either had at least one dose of a bivalent HPV vaccine more than a year ago, or you have never had any HPV vaccine.
- You have not had abnormal Pap tests or cervical biopsies showing certain changes.
- You have not had genital warts, or certain cancers or precancerous conditions.
- You have never tested positive for HPV.
- You do not have a weakened immune system or take medications that affect your immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an 11-type HPV vaccine to prevent infection from multiple HPV strains. If you enroll, you’ll receive scheduled vaccine doses and have health and gynecologic check-ins to see how well the vaccine works and is tolerated.
This trial tests a 9-type HPV vaccine to see how well it works, how it helps the body build protection, and whether it’s safe. It’s for healthy Chinese women who have not had HPV vaccination before and meet specific health and timing requirements.
This trial tests whether different batches of the HPV 9-valent vaccine work consistently. It's for Chinese women aged 18 to 30 who have not had any HPV vaccine or abnormal cervical screening results.
This trial tests whether a vaccine against HPV can help prevent pre-cancerous lesions from coming back after you've had them. It's for people who have had high-grade pre-cancerous lesions but haven't yet been treated for them.
This Phase 1 study tests FluBHPVE6E7, a new treatment designed to help the immune system respond to HPV16. It mainly checks safety and the best dose, and may help your body clear or control HPV over time.
This study looks at how well the HPV vaccine works in women who have already been exposed to the virus through sexual activity. It aims to understand the immune response and potentially improve protection against HPV-related cancers.
Hear when a new Papillomavirus Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.